Clinical Trial Update: Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

View source ↗

Summary

This clinical trial update reports on evaluating the efficacy of anti-HER2 antibody-drug conjugates for locally advanced or metastatic bladder cancer using orga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Bladder Cancer | Status: RECRUITING